BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8190001)

  • 1. Activity of D-glucarate analogues: synergistic antiproliferative effects with retinoid in cultured human mammary tumor cells appear to specifically require the D-glucarate structure.
    Curley RW; Humphries KA; Koolemans-Beynan A; Abou-Issa H; Webb TE
    Life Sci; 1994; 54(18):1299-303. PubMed ID: 8190001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of growth inhibition of mammary carcinomas by glucarate and the glucarate: retinoid combination.
    Webb TE; Abou-Issa H; Stromberg PC; Curley RC; Nguyen MH
    Anticancer Res; 1993; 13(6A):2095-9. PubMed ID: 8297119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Basis for the anti-tumor and chemopreventive activities of glucarate and the glucarate:retinoid combination.
    Abou-Issa H; Dwivedi C; Curley RW; Kirkpatrick R; Koolemans-Beynen A; Engineer FN; Humphries KA; el-Masry W; Webb TE
    Anticancer Res; 1993; 13(2):395-9. PubMed ID: 8517653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic interaction between 13-cis-retinoic acid and glucarate: activity against rat mammary tumor induction and MCF-7 cells.
    Abou-Issa H; Koolemans-Beynen A; Minton JP; Webb TE
    Biochem Biophys Res Commun; 1989 Sep; 163(3):1364-9. PubMed ID: 2783140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth suppression of human breast carcinoma cells in culture by N-(4-hydroxyphenyl)retinamide and its glucuronide and through synergism with glucarate.
    Bhatnagar R; Abou-Issa H; Curley RW; Koolemans-Beynen A; Moeschberger ML; Webb TE
    Biochem Pharmacol; 1991 May; 41(10):1471-7. PubMed ID: 1826840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics relevant to the anti-carcinogenic and anti-tumor activities of glucarate and the synergistic combination of glucarate:retinoid in the rat.
    Webb TE; Pham-Nguyen MH; Darby M; Hamme AT
    Biochem Pharmacol; 1994 Apr; 47(9):1655-60. PubMed ID: 8185680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiproliferative effect of dietary glucarate on the Sprague-Dawley rat mammary gland.
    Walaszek Z; Hanausek M; Sherman U; Adams AK
    Cancer Lett; 1990 Jan; 49(1):51-7. PubMed ID: 2302696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary glucarate as anti-promoter of 7,12-dimethylbenz[a]anthracene-induced mammary tumorigenesis.
    Walaszek Z; Hanausek-Walaszek M; Minton JP; Webb TE
    Carcinogenesis; 1986 Sep; 7(9):1463-6. PubMed ID: 3091283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential use of D-glucaric acid derivatives in cancer prevention.
    Walaszek Z
    Cancer Lett; 1990 Oct; 54(1-2):1-8. PubMed ID: 2208084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of calcium glucarate on beta-glucuronidase activity and glucarate content of certain vegetables and fruits.
    Dwivedi C; Heck WJ; Downie AA; Larroya S; Webb TE
    Biochem Med Metab Biol; 1990 Apr; 43(2):83-92. PubMed ID: 2346674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of retinoid binding affinity to retinoic acid receptor alpha with retinoid inhibition of growth of estrogen receptor-positive MCF-7 mammary carcinoma cells.
    Dawson MI; Chao WR; Pine P; Jong L; Hobbs PD; Rudd CK; Quick TC; Niles RM; Zhang XK; Lombardo A
    Cancer Res; 1995 Oct; 55(19):4446-51. PubMed ID: 7671258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism, uptake, and excretion of a D-glucaric acid salt and its potential use in cancer prevention.
    Walaszek Z; Szemraj J; Narog M; Adams AK; Kilgore J; Sherman U; Hanausek M
    Cancer Detect Prev; 1997; 21(2):178-90. PubMed ID: 9101079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of azoxymethane-induced rat colon carcinogenesis by potassium hydrogen D-glucarate.
    Yoshimi N; Walaszek Z; Mori H; Hanausek M; Szemraj J; Slaga TJ
    Int J Oncol; 2000 Jan; 16(1):43-8. PubMed ID: 10601547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumour synergism between non-toxic dietary combinations of isotretinoin and glucarate.
    Abou-Issa H; Koolemans-Beynen A; Meredith TA; Webb TE
    Eur J Cancer; 1992; 28A(4-5):784-8. PubMed ID: 1388036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of 99mTc-glucarate as a breast cancer imaging agent in a xenograft animal model.
    Gambini JP; Cabral P; Alonso O; Savio E; Figueroa SD; Zhang X; Ma L; Deutscher SL; Quinn TP
    Nucl Med Biol; 2011 Feb; 38(2):255-60. PubMed ID: 21315281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New synthetic retinoids: effects on proliferation and differentiation.
    Nastruzzi C; Simoni D; Manfredini S; Barbieri R; Feriotto G; Baraldi PG; Spandidos D; Guarneri M; Gambari R
    Anticancer Res; 1989; 9(5):1377-83. PubMed ID: 2589824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium-D-glucarate.
    Altern Med Rev; 2002 Aug; 7(4):336-9. PubMed ID: 12197785
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Putative metabolites derived from dietary combinations of calcium glucarate and N-(4-hydroxyphenyl)retinamide act synergistically to inhibit the induction of rat mammary tumors by 7,12-dimethylbenz[a]anthracene.
    Abou-Issa HM; Duruibe VA; Minton JP; Larroya S; Dwivedi C; Webb TE
    Proc Natl Acad Sci U S A; 1988 Jun; 85(12):4181-4. PubMed ID: 2967969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Excentric cleavage products of beta-carotene inhibit estrogen receptor positive and negative breast tumor cell growth in vitro and inhibit activator protein-1-mediated transcriptional activation.
    Tibaduiza EC; Fleet JC; Russell RM; Krinsky NI
    J Nutr; 2002 Jun; 132(6):1368-75. PubMed ID: 12042460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of antioxidative activity of calcium-D-glucarate, sodium-D-gluconate and D-glucono-1,4-lactone in a human blood platelet model.
    Saluk-Juszczak J
    Platelets; 2010; 21(8):632-40. PubMed ID: 20873960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.